Sanofi-Synthelabo Research is categorized under Wholesale Pharmaceutical Products in Atlanta, GA .
Sanofi-Synthelabo Research was established in 0, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Lativia Ray-Alston, Vice President at the company’s single location by writing to 3350 Riverwood Parkway Se, Atlanta, Georgia GA 30339 or by phoning (404) 303-5500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sanofi-Synthelabo Research |
| Contact Person: | Lativia Ray-Alston, Vice President |
| Address: | 3350 Riverwood Parkway Se, Atlanta, Georgia 30339 |
| Phone Number: | (404) 303-5500 |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
Sanofi-Synthelabo Research was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Lativia Ray-Alston, Vice President for inquiries that concern Sanofi-Synthelabo Research by calling the company number (404) 303-5500, as your correspondence is most welcome. Additionally, the physical location of the single location of Sanofi-Synthelabo Research can be found at the coordinates 33.878163,-84.459161 as well as the street address 3350 Riverwood Parkway Se in Atlanta, Georgia 30339.
For its online presence, you may visit Sanofi-Synthelabo Research’s website at and engage with its social media outlets through on Twitter and on Facebook.